ABBVIE INC. vs. Silence Therapeutics Plc American Depository Share
ABBV
ABBVIE INC.
$276.47 +1.49%
VS SLNSilence Therapeutics Plc American Depository Share
$12.25 +0.41%
ABBVIE INC. and Silence Therapeutics Plc American Depository Share are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | SLN | |
|---|---|---|
| Market Cap | $481.40 billion | $758.28 million |
| Revenue (TTM) | — | $615,000 |
| Net Income (TTM) | — | $-59,953,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | SLN | |
|---|---|---|
| Price / Book | — | 19.71 |
| Price / Sales | — | 1232.98 |
ABBV and SLN split the valuation factors evenly.
Profitability
| ABBV | SLN | |
|---|---|---|
| Net Margin | — | -9748.46% |
| Return on Equity | — | -155.84% |
ABBV and SLN split the profitability factors evenly.
Dividend
| ABBV | SLN | |
|---|---|---|
| Dividend Yield | 2.50% | — |
ABBV and SLN split the dividend factors evenly.
Risk & Sentiment
| ABBV | SLN | |
|---|---|---|
| Short Interest | 0.85% | 0.00% |
SLN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, SLN overview, SLN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.